Keywords: head-to-head, aricept, superior, reminyl, results, first, 12-week

Head-to-head, Aricept superior to Reminyl

Article | 15 April 2002

• Print This

Results from the first head-to-head, 12-week, 120-patient studycomparing Pfizer/Eisai's Aricept (donepezil) - which produced 2001 sales of $1.38 billion - and ...

Enjoying this article? To continue reading you need to login or subscribe.